Photodynamic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation.
L5178Y-R mouse lymphoma (LY-R) cells undergo rapid apoptosis when treated with photodynamic therapy (PDT) sensitized with the silicon phthalocyanine Pc 4. In this study we show that cytochrome c is released into the cytosol within 10 min of an LD99.9 dose of PDT. Cellular respiration is inhibited by 42% at 15 min, and 60% at 30 min after PDT treatment, and caspase 3-like protease activity is elevated by 15 min post-PDT. In digitonin-permeabilized cells addition of cytochrome c to the respiration buffer reverses PDT-induced inhibition of state 3 respiration via Complex I by 40-60%, and via Complex III by 50-90%. In contrast, extramitochondrial cytochrome c does not stimulate respiration in permeabilized control cells, and catalyzes only a low rate of oxygen consumption via electron transfer to cytochrome b5 on the outer mitochondrial membrane. These results demonstrate that PDT-induced inhibition of respiration is primarily due to leakage of cytochrome c into the cytosol rather than to damage to the major enzyme complexes of the electron transport chain. Whether or not inhibition of respiration influences the time course or extent of Pc 4-PDT-induced apoptosis in LY-R cells is not clear at the present time.
Varnes
M E
ME
Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio, 44106-4942, USA. mxv2@po.cwru.edu
Chiu
S M
SM
Xue
L Y
LY
Oleinick
N L
NL
D000818:Animals; D017209:Apoptosis / Q000528:radiation effects*; D020169:Caspases / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000187:drug effects; D019069:Cell Respiration / Q000528:radiation effects*; D003574:Cytochrome c Group / Q000378:metabolism*; D004072:Digitonin / Q000494:pharmacology; D004579:Electron Transport; D014450:Electron Transport Complex III / Q000378:metabolism; D004789:Enzyme Activation / Q000528:radiation effects; D007211:Indoles / Q000378:metabolism; D008223:Lymphoma / Q000532:radiotherapy*; D051379:Mice; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000378:metabolism; D017646:Organosilicon Compounds / Q000378:metabolism; D010101:Oxygen Consumption / Q000528:radiation effects; D010778:Photochemotherapy / Q000009:adverse effects*; D011838:Radiation-Sensitizing Agents / Q000378:metabolism; D012821:Silanes; D014407:Tumor Cells, Cultured
D003574:Cytochrome c Group; D007211:Indoles; D017646:Organosilicon Compounds; D011838:Radiation-Sensitizing Agents; D012821:Silanes; C082854:silicon phthalocyanine; C052464:bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon; D016660:NAD(P)H Dehydrogenase (Quinone); D020169:Caspases; D014450:Electron Transport Complex III; D004072:Digitonin